CardioCareLive

CME Presentations

Hereditary Transthyretin Amyloidosis


Presentations


Speakers

  • Roy L. Freeman, MD

    Roy L. Freeman, MD

    Roy L. Freeman, MD

    Professor of Neurology

    Roy Freeman, MD, is a professor of neurology at Harvard Medical School and director of the Center for Autonomic and Peripheral Nerve Disorders in the Department of Neurology at Beth Israel Deaconess Medical Center in Boston, Massachusetts. Dr Freeman’s research encompasses the neurological complications of diabetes and other peripheral neuropathies, neuropathic pain, the autonomic complications of Parkinson’s disease and multiple system atrophy, biomarkers in neurodegenerative diseases, and the diagnosis and treatment of autonomic and peripheral nervous system disorders. He is the principal investigator on National Institutes of Health-funded studies on the neurological complications of diabetes and biomarker development in alpha-synucleinopathies.

CME Information

Hereditary Transthyretin Amyloidosis: Addressing Barriers to Diagnosis and Evolving Disease Management


LEARNING OBJECTIVES

  • Identify the neurologic, autonomic, cardiac symptoms of hATTR amyloidosis in the context of the differential diagnosis for hATTR amyloidosis
  • Delineate the methods of assessment for hereditary hATTR amyloidosis, including sensorimotor function, autonomic dysfunction, cardiac function, renal function
  • Appraise clinical safety and efficacy data for new and emerging therapeutic agents for the treatment of hATTR amyloidosis

Acknowledgement

This activity is supported by educational grants from Akcea Therapeutics, Inc. and Alnylam Pharmaceuticals

Tuition

Complimentary

ACCREDITATION STATEMENT

The activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and PlatformQ Health Education, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS

Live Internet Activity

Albert Einstein College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Material

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER CREDITS

The American Academy of Nurse Practitioners (AANP) and American Nurses Credentialing Center (ANCC) accept AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

DATE OF RELEASE/EXPIRATION

Live Internet Activity
December 11, 2018 from 11:00 AM – 12:00 PM ET

Enduring Material
The enduring material will be available from December 11, 2018 to May 11, 2019.

Intended Audience

This activity is intended for neurologists, cardiologists, critical care specialists, medical fellows, nurse practitioners, pharmacists, and other health care professionals who treat patients with amyloidosis. Other clinicians in urology, nephrology, gastroenterology, ophthalmology, hematology-oncology, pathology, surgery, radiology, internal medicine and primary care may also benefit from this educational activity.

ESTIMATED TIME TO COMPLETE

This activity consists of one session, which should take approximately 1 hour to complete.

METHOD OF PARTICIPATION

There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the posttest and activity evaluation. It is estimated that this module will take approximately 1 hour to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the posttest.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FACULTY DISCLOSURE

The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.

The Albert Einstein College of Medicine also requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.

Presenter

Roy Freeman, MD, MB, ChB

Michael J. Polydefkis, MD

Rodney H. Falk, MD Has nothing to disclose relevant to this activity.

Peer Reviewer

David Kaufman, MD Has nothing to disclose relevant to this activity.

Providers

Einstein–Montefiore Center for Continuing Medical Education The Center for Continuing Medical Education (CCME) staff at Albert Einstein College of Medicine has no disclosures to report relevant to this activity.

PlatformQ Health Education, LLC

Anne Roc, Senior Medical Director Has nothing to disclose relevant to this activity.

Elizabeth del Nido, Program Manager Has nothing to disclose relevant to this activity.

Contact Information

Please send all inquiries to: Montefiore Medical Center, CCME, 3301 Bainbridge Avenue, Bronx, New York 10467, or via phone at (718) 920-6674, or via fax to (718) 798-2336, or via email to cme@montefiore.org.

For issues with your CME Certificate, please contact NeuroSeriesLive at 877-394-1306 or at Support@NeuroSeriesLive.com.

DISCLAIMERS (if applicable):

The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Albert Einstein College of Medicine, NeuroSeriesLive, CardioCareLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.